Anne Wojcicki's nonprofit TTAM acquires 23andMe for $305 million, ending the gene-testing pioneer's bankruptcy saga. The deal still faces state regulators' objections over genetic data control.

A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by its former CEO Anne Wojcicki, effectively putting her back in control of the bankrupt genetics company.

Anne Wojcicki's nonprofit, TTAM Research Institute, has received court approval to acquire 23andMe, the genetic testing company she co-founded.

Anne Wojcicki, chief executive officer and co-founder of 23andMe Inc., speaks during the TechCrunch Disrupt 2017 in San Francisco, Sept. 19, 2017.

Anne Wojcicki’s nonprofit gets court approval to buy 23andMe for $305 million Under the deal, TTAM will acquire 23andMe’s signature “Personal Genome Service” provided through the company ...

NEW YORK (AP) — Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight. That means Wojcicki’s nonprofit TTAM ...

NEW YORK (AP) — Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight.

NEW YORK (AP) — Anne Wojcicki's bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight.